Wells Fargo’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.66M | Sell |
197,810
-86,433
| -30% | -$2.21M | ﹤0.01% | 2649 |
|
|
2025
Q4 | $8.25M | Buy |
284,243
+178,986
| +170% | +$4.58M | ﹤0.01% | 2216 |
|
|
2025
Q3 | $1.98M | Sell |
105,257
-91,043
| -46% | -$1.44M | ﹤0.01% | 3309 |
|
|
2025
Q2 | $2.75M | Sell |
196,300
-2,059
| -1% | -$28.9K | ﹤0.01% | 2948 |
|
|
2025
Q1 | $3.1M | Buy |
198,359
+145,904
| +278% | +$2.06M | ﹤0.01% | 2793 |
|
|
2024
Q4 | $731K | Buy |
52,455
+16,682
| +47% | +$183K | ﹤0.01% | 3929 |
|
|
2024
Q3 | $333K | Sell |
35,773
-792
| -2% | -$7.82K | ﹤0.01% | 4262 |
|
|
2024
Q2 | $340K | Buy |
36,565
+8,807
| +32% | +$79.6K | ﹤0.01% | 4161 |
|
|
2024
Q1 | $275K | Buy |
27,758
+6,144
| +28% | +$45.9K | ﹤0.01% | 4270 |
|
|
2023
Q4 | $69.8K | Sell |
21,614
-65,164
| -75% | -$177K | ﹤0.01% | 5120 |
|
|
2023
Q3 | $461K | Sell |
86,778
-19,972
| -19% | -$170K | ﹤0.01% | 3838 |
|
|
2023
Q2 | $1.02M | Buy |
106,750
+44,115
| +70% | +$490K | ﹤0.01% | 3464 |
|
|
2023
Q1 | $689K | Buy |
62,635
+59,195
| +1,721% | +$856K | ﹤0.01% | 3631 |
|
|
2022
Q4 | $50.9K | Sell |
3,440
-422
| -11% | -$7.37K | ﹤0.01% | 4846 |
|
|
2022
Q3 | $73K | Buy |
3,862
+196
| +5% | +$4.44K | ﹤0.01% | 4763 |
|
|
2022
Q2 | $78K | Sell |
3,666
-135,069
| -97% | -$2.77M | ﹤0.01% | 4784 |
|
|
2022
Q1 | $2.67M | Sell |
138,735
-2,827
| -2% | -$47.8K | ﹤0.01% | 3019 |
|
|
2021
Q4 | $2.94M | Sell |
141,562
-631,652
| -82% | -$12.6M | ﹤0.01% | 3109 |
|
|
2021
Q3 | $18.5M | Sell |
773,214
-124,758
| -14% | -$2.85M | ﹤0.01% | 1720 |
|
|
2021
Q2 | $24.5M | Buy |
897,972
+21,388
| +2% | +$602K | 0.01% | 1533 |
|
|
2021
Q1 | $25.4M | Buy |
876,584
+233,128
| +36% | +$7.28M | 0.01% | 1479 |
|
|
2020
Q4 | $18.1M | Buy |
643,456
+87,093
| +16% | +$2.13M | ﹤0.01% | 1628 |
|
|
2020
Q3 | $16.3M | Buy |
556,363
+29,236
| +6% | +$781K | ﹤0.01% | 1544 |
|
|
2020
Q2 | $15.9M | Buy |
527,127
+113,356
| +27% | +$3.28M | ﹤0.01% | 1508 |
|
|
2020
Q1 | $12.3M | Buy |
+413,771
| New | +$11.1M | ﹤0.01% | 1535 |
|
Other funds holding ARQT
SCM
FLSM
RCMNY
PCH
VCM
GGHC
